Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan N Bella

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
American Journal of Cardiovascular Disease|January 22, 2025
Burden and predictors of mortality related to cardiogenic shock in the South Bronx PopulationNismat Javed, Vikram Itare, Sai Vishnu Vardhan Allu, et al.
The American Journal of Cardiology|December 28, 2004
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy)Michael H Olsen, Kristian Wachtell, Jonathan N Bella, et al.
Journal of Hypertension|March 27, 2003
Pulse pressure/stroke index and left ventricular geometry and function: the LIFE StudyVittorio Palmieri, Jonathan N Bella, Mary J Roman, et al.
American Heart Journal|December 18, 2002
Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) studyKristian Wachtell, Björn Dahlöf, Jens Rokkedal, et al.
American Heart Journal|January 31, 2006
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS)Jorge R Kizer, Jonathan N Bella, Vittorio Palmieri, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 14, 2007
Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart StudyVittorio Palmieri, Mary J Roman, Jonathan N Bella, et al.
American Journal of Hypertension|March 9, 2005
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart StudyGiovanni de Simone, Jorge R Kizer, Marcello Chinali, et al.
Journal of Hypertension|July 20, 2002
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction studyRichard B Devereux, Vittorio Palmieri, Jennifer E Liu, et al.
American Journal of Hypertension|November 11, 2005
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudyMichael H Olsen, Kristian Wachtell, Jonathan N Bella, et al.
Physiological Genomics|December 15, 2005
BDNF-mediated enhancement of inflammation and injury in the aging heartDongqing Cai, Jacquelyne M Holm, Inga J Duignan, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
American Journal of Cardiovascular Disease|January 22, 2025
Burden and predictors of mortality related to cardiogenic shock in the South Bronx PopulationNismat Javed, Vikram Itare, Sai Vishnu Vardhan Allu, et al.
The American Journal of Cardiology|December 28, 2004
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy)Michael H Olsen, Kristian Wachtell, Jonathan N Bella, et al.
Journal of Hypertension|March 27, 2003
Pulse pressure/stroke index and left ventricular geometry and function: the LIFE StudyVittorio Palmieri, Jonathan N Bella, Mary J Roman, et al.
American Heart Journal|December 18, 2002
Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) studyKristian Wachtell, Björn Dahlöf, Jens Rokkedal, et al.
American Heart Journal|January 31, 2006
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS)Jorge R Kizer, Jonathan N Bella, Vittorio Palmieri, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 14, 2007
Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart StudyVittorio Palmieri, Mary J Roman, Jonathan N Bella, et al.
American Journal of Hypertension|March 9, 2005
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart StudyGiovanni de Simone, Jorge R Kizer, Marcello Chinali, et al.
Journal of Hypertension|July 20, 2002
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction studyRichard B Devereux, Vittorio Palmieri, Jennifer E Liu, et al.
American Journal of Hypertension|November 11, 2005
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudyMichael H Olsen, Kristian Wachtell, Jonathan N Bella, et al.
Physiological Genomics|December 15, 2005
BDNF-mediated enhancement of inflammation and injury in the aging heartDongqing Cai, Jacquelyne M Holm, Inga J Duignan, et al.
Pageof 8